FDA Approves New Treatment to Prevent Bleeding in Certain Patients with Hemophilia A
SILVER SPRING, Md., Nov. 16, 2017 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hem... Biopharmaceuticals, FDA Genentech, Hemlibra, emicizumab, hemophilia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Bleeding | Food and Drug Administration (FDA) | Haemophilia | Hemophilia | Marketing | Pediatrics